TWIRLA

Levonorgestrel/ethinyl estradiol · Agile Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TWIRLA, covering 2018-07-03 to 2026-08-27. Get the full timeline:

Most recent: Clinical Trial Results: A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal System [Phase 4]

See pricing